philip philip, md explains how to integrate regorafenib and trifluridine for 2nd line mcrc treatment
Published 8 years ago • 17 plays • Length 0:51
Download video MP4
Download video MP3
Similar videos
-
0:56
philip philip, md on stivarga (regorafenib) dosage in 2nd line treatment of mcrc
-
0:25
alan venook, md on integrating regorafenib and trifluridine into the 2nd line treatment of mcrc
-
1:36
philip philip, md, shares his perspective on using tas-102 and regorafenib in crc patients
-
1:35
philip philip, md, on integrating immunotherapy into existing treatment regimens for crc patients
-
1:47
alan venook, md relays the optimal dose for regorafenib (stivarga) in the 2nd line treatment of mcrc
-
1:45
jeffrey a. meyerhardt, md explains integration of stivarga and lonserf in later lines of treatment
-
2:19
tanios bekali-saab, md, on utilizing regorafenib (stivarga) and trifluridine (lonserf)
-
18:55
emerging treatment options for mcrc patients in the late-line setting
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
3:04
treatment goals in refractory mcrc
-
2:52
metastatic colorectal cancer: trifluridine/tiripacil or regorafenib?
-
1:44
an insight into colon cancer ep 2: the tests
-
7:43
therapy in the salvage setting of mcrc
-
0:34
dr. eng: second-line options to prolong survival
-
1:14
colon polyps...colon cancer. meditoons™
-
24:37
current management of myelofibrosis - ronald hoffman, md
-
2:21
how to avoid surgery for colon polyps with colorectal surgeon dr. robert cloud
-
2:09
phil sarges, md | "colon cancer"
Clip.africa.com - Privacy-policy